Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001213900-24-097876
Filing Date
2024-11-14
Accepted
2024-11-14 09:06:06
Documents
1
Period of Report
2024-09-30
Effectiveness Date
2024-11-14

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea0221223-nt10q_cero.htm NT 10-Q 19144
  Complete submission text file 0001213900-24-097876.txt   20400
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-40877 | Film No.: 241457629
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)